Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021

SELL
$126.27 - $191.71 $1,641 - $2,492
-13 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$48.82 - $82.53 $634 - $1,072
13 New
13 $1,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.7B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Associated Banc Corp Portfolio

Follow Associated Banc Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.